MORGAN STANLEY - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$8,688,505
+61.4%
1,817,679
+43.5%
0.00%0.0%
Q2 2023$5,383,617
-18.8%
1,266,733
+1.4%
0.00%0.0%
Q1 2023$6,633,507
-14.1%
1,249,248
+1.6%
0.00%0.0%
Q4 2022$7,719,168
-39.8%
1,229,167
+1.2%
0.00%
-50.0%
Q3 2022$12,815,000
+266.9%
1,214,592
+88.8%
0.00%
Q2 2022$3,493,000
+87.5%
643,183
+217.0%
0.00%
Q1 2022$1,863,000
+19.7%
202,888
+96.8%
0.00%
Q4 2021$1,556,000
+23.6%
103,068
+95.4%
0.00%
Q3 2021$1,259,00052,7560.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders